Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00903539
Other study ID # 1180-001
Secondary ID
Status Completed
Phase N/A
First received May 14, 2009
Last updated January 26, 2012
Start date January 2009
Est. completion date May 2011

Study information

Verified date January 2012
Source Interrad Medical
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

To prospectively monitor the safety and performance of the catheter securement device in subjects whose catheter is secured with the Interrad Medical SecureAcath device.


Description:

Peripherally inserted central catheters (PICCs) and Central Venous Catheter (CVC) are widely used to deliver fluids directly to the central venous system and can remain in place for as short as a few days to as long as months. One of the highest risks in the use of these catheters is infection, both local and systemic. Currently, these catheters are secured by either sutures or adhesive patches. Sutures can create additional potential entry points for bacteria whereas both sutures and adhesive securement patches hold the catheter hub to the skin resulting in increased difficulty cleaning around the catheter entry site. Furthermore, securing a catheter outside the skin away from the catheter entry point, as with sutures or adhesive securement patches may potentiate pistoning of the catheter which is also believed to possibly increase infection risks. A second risk of intravenous catheter use is dislodgement during normal use and site maintenance. These catheters are often manipulated multiple times a day for blood sampling or injection of fluids. During manipulation, the catheter can be dislodged thus requiring an unplanned replacement of the catheter.

Interrad Medical has developed a means to secure indwelling catheters using a small subcutaneous anchor. With this system, cleaning around the catheter entry site is made easier and can be more thorough. The system is also designed to minimize the risk of catheter dislodgement because once the anchor is deployed, the catheter remains secured. This may simplify dressing changes compared to adhesive devices such as Statlock, which requires the catheter be released from the device and therefore be unsecured during dressing changes.

The objective of this post-market study is to monitor the safety and performance of the SecurAcath when used to secure the catheter to the insertion site via a subcutaneous anchor. The data collected may provide insight for future enhancements to improve the safety and utility of the device. It also provides a means for an early warning of any identified safety issues, and allows physicians to share their experiences thereby improve the quality of care provided to the patients.


Recruitment information / eligibility

Status Completed
Enrollment 217
Est. completion date May 2011
Est. primary completion date May 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Age 18 or older

- Requires an intravenous catheter to be placed

Exclusion Criteria:

- Inability to understand the study or a history of non-compliance with medical advice.

- Unwilling or unable to sign Informed Consent Form (ICF).

- Had a previous catheter placed in the same side within the last 3 months.

- Known central venous thrombosis or occlusion or stenosis on the side of the body to be used for the catheter.

- History of upper extremity venous thrombosis on the side of the body to be used for the catheter.

- Known hypercoagulable disorder.

- Diffuse skin inflammatory condition or rashes on the side to be used for the catheter line.

- Peripheral chemotherapy therapy in the same side as that to be used for the catheter line within 3 months.

- Known hypersensitivity to nickel.

- Any infection associated with positive blood cultures that are still present after 48 hours of antibiotic therapy.

- Previous mastectomy or axillary lymph node dissection on the same side as catheter implant.

- Subjects on chronic or recurrent systemic steroid medications for 6 months or longer.

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Device:
SecurAcath Securement System
Subcutaneous catheter securement system

Locations

Country Name City State
United States Albany Medical Center Albany New York
United States Great Basin Imaging Carson City Nevada
United States North Memorial Hospital - Minneapolis Radiology Robbinsdale Minnesota
United States HealthEast St. Joseph's Hospital St. Paul Minnesota

Sponsors (1)

Lead Sponsor Collaborator
Interrad Medical

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Device Securement Success: defined as the percent of devices implanted and explanted without malfunction or device related complications attributed to the subcutaneous securement system. Timeframe is the length of time the patient has the catheter in place. Can vary depending on the indication for the catheter (anywhere from 48 hours post-procedure to 6 months or more). Yes
See also
  Status Clinical Trial Phase
Recruiting NCT03801811 - Use of the Skin Glue in the Placement of Central Venous Catheters Port a Catch
Completed NCT02888431 - Correlation of Arterial and Venous Lactate and Base Deficit Values N/A
Completed NCT03647293 - Less Pain in Neonates During Central Lines Insertion N/A
Completed NCT02009189 - Taurolidine Lock in Long Term Parenteral Nutrition Phase 4
Recruiting NCT05124821 - Evaluation of Performance Over Dwell Time and Safety of the Central-venous Catheters Certofix® Paed
Completed NCT03025178 - Optimal Insertion Depth of Left Internal Jugular Vein Catheter in Infants N/A
Not yet recruiting NCT05751395 - Siting Central Venous Catheters Precisely While Performing the Access Procedure
Completed NCT04630236 - Ultrasound Guided Positioning of Central Venous Catheters N/A
Completed NCT05176886 - Correct Tip Position of Central Venous Catheters
Recruiting NCT05956028 - Efficacy of Ultrasound-guided Internal Jugular Vein Versus Supraclavicular Subclavian Vein Cannulation in Neonates and Infants Less Than 5 kg. N/A
Active, not recruiting NCT02472132 - The Use of Point of Care Ultra Sound for Correct Placement of Central Venous Catheter N/A
Completed NCT02314520 - Complications Associated With Central Venous Access in the NSICU: PICC vs CVC N/A
Completed NCT03502980 - Safety and Efficacy of Midline and PICC N/A
Completed NCT04117776 - Skin Decolonization of Children Hospitalized in Intensive Care Unit
Completed NCT03879954 - US-guided OOP Internal Jugular Vein Vs IP Supraclavicular Subclavian Vein Catheterization in ICU N/A
Completed NCT04733547 - Spectral Analysis of Central Venous Pressure Waveform
Completed NCT04637347 - SC vs IC Approach for US-guided SC Vein Catheterization N/A
Completed NCT03109574 - Access in Dialysis for Better Outcomes in Patient Therapy N/A
Completed NCT04597021 - Wireless US-guided CVC Placement in Infants
Recruiting NCT03683563 - The Impact of Different Citrate Concentrations as Locking Solutions on Development of Biofilm and Function of Hemodialysis Catheters N/A